Broadwood Capital’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.5M Hold
11,410,100
2.2% 6
2025
Q1
$34.9M Buy
11,410,100
+5,165,695
+83% +$15.8M 2.83% 5
2024
Q4
$14.9M Buy
6,244,405
+1,315,339
+27% +$3.13M 1.16% 6
2024
Q3
$14M Hold
4,929,066
1.08% 6
2024
Q2
$14.5M Buy
4,929,066
+2,420,000
+96% +$7.14M 1.1% 6
2024
Q1
$7.35M Hold
2,509,066
0.55% 6
2023
Q4
$6.27M Hold
2,509,066
0.53% 6
2023
Q3
$7.83M Sell
2,509,066
-1
-0% -$3 0.7% 6
2023
Q2
$11.5M Buy
2,509,067
+1,341,382
+115% +$6.17M 0.86% 6
2023
Q1
$8.28M Hold
1,167,685
0.58% 6
2022
Q4
$7.49M Hold
1,167,685
0.63% 6
2022
Q3
$17M Hold
1,167,685
1.3% 7
2022
Q2
$21M Buy
1,167,685
+300,188
+35% +$5.4M 1.58% 6
2022
Q1
$25.9M Hold
867,497
1.86% 6
2021
Q4
$37.6M Hold
867,497
2.31% 6
2021
Q3
$61.8M Buy
867,497
+28,673
+3% +$2.04M 3.15% 6
2021
Q2
$96.3M Hold
838,824
4.3% 6
2021
Q1
$87.1M Buy
838,824
+103,014
+14% +$10.7M 4.63% 5
2020
Q4
$35.2M Hold
735,810
2.09% 6
2020
Q3
$20.5M Hold
735,810
1.61% 6
2020
Q2
$28.1M Buy
735,810
+52,500
+8% +$2.01M 2.2% 6
2020
Q1
$33.5M Buy
683,310
+69,573
+11% +$3.41M 3.91% 5
2019
Q4
$27.6M Buy
613,737
+58,824
+11% +$2.65M 3.18% 6
2019
Q3
$23.3M Buy
554,913
+150,000
+37% +$6.3M 3.24% 6
2019
Q2
$20.2M Hold
404,913
2.52% 6
2019
Q1
$32M Buy
404,913
+26,666
+7% +$2.11M 3.92% 6
2018
Q4
$10.4M Hold
378,247
1.47% 6
2018
Q3
$18.9M Hold
378,247
1.76% 6
2018
Q2
$19.3M Hold
378,247
2.22% 6
2018
Q1
$15.9M Buy
378,247
+198,413
+110% +$8.33M 2.31% 6
2017
Q4
$16.7M Hold
179,834
2.33% 5
2017
Q3
$27.2M Buy
179,834
+27,000
+18% +$4.08M 4.5% 5
2017
Q2
$15.9M Hold
152,834
2.92% 5
2017
Q1
$18.2M Buy
152,834
+21,250
+16% +$2.53M 3.47% 5
2016
Q4
$18.6M Hold
131,584
3.15% 6
2016
Q3
$13.3M Buy
131,584
+76,923
+141% +$7.75M 2.27% 8
2016
Q2
$3.89M Hold
54,661
0.75% 9
2016
Q1
$5.04M Hold
54,661
1.04% 9
2015
Q4
$6.83M Buy
+54,661
New +$6.83M 1.15% 8